ClinicalTrials.gg
CompletedNCT02622919Updated Sep 11, 2026Results posted

Investigation Into the Functional Performance of a New Thermoplastic Elastomer (TPE) Transtibial Liner

An interventional study of TPE Liner in Amputation Stumps, sponsored by Össur Iceland ehf. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Össur Iceland ehf (part of Embla Medical hf.) · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The clinical investigation is designed as an uncontrolled open prospective, multicenter, 2 group, pre-test post-test study. Testing will be conducted in the USA and Canada at 3-6 clinics, depending on enrolment requirements. 20 subjects currently using the comparator liner will be recruited: 10 using cushion/sleeve and 10 using pin-lock.

The study consists of 4 study events, requiring subjects to visit the clinic at least 4 times; as this study requires the manufacturing of a new socket, more than one iterations might be required. These events will be as follows

Read the detailed description

The study is of an uncontrolled open prospective multicentre 2 group pre-test post-test design.

i) Recruitment phase Potential subjects will be identified from the customer base of the Local Principal Investigator (LPI). LPI evaluates, based on previous experience of interaction with and servicing of patients, if a potential participant is cognitively capable. If a potential participant fits the inclusion and exclusion criteria the LPI will contact them via telephone. During the telephone call the LPI will verify if they are interested in participating in a study. If interest is expressed at this point they will answer some screening questions and if the eligibility criteria are met an appointment will be made for the clinical visit and signing of the ICF. Questions relating to the duration of the study, number of clinical visits required and the investigational device will be answered.

The LPI will communicate to the study monitor the number of users he has identified that meet the inclusion criteria and are willing to participate.

ii) Test procedure 3-10 users will be recruited at each site. User Profile instrument will be filled in at the initial visit. It will be filled in by the CPI/LPI with input from the subject.

Baseline instrument will also be filled in at the initial visit. It consists of 5 parts: Usability, Suspension Questionnaire, PEQ - Residual Limb Health (PEQ-RLH), Comfort and other (noise and satisfaction). They only include VAS items and comment boxes. Additionally the pistoning test output is documented at the end.

The first part, socket fit comfort, of the Socket fitting instrument will be administrated each time as required, depending on iterations needed. CPO feedback, usability and comfort will only be administrated when the subject comes in for the first time for the fitting.

The 2 week follow up instrument will be administrated at the 2 week post successful fitting visit. It consists of 5 parts: Usability, Suspension Questionnaire, PEQ-RLH, and Comfort and Other; same as Baseline. Additionally the pistoning test output for both the trial liner (ICEROSS TPE) and is ICEROSS COMFORT is documented at the end.

The Retrofitting instrument is also administrated at study event 3 (expected visit 3).

The instrument used at the 6 month follow up consists of 4 parts: Suspension Questionnaire, PEQ-RLH, Comfort, and Other. The Other part has additional questions compared to the instruments used at earlier visits.

All items are in-house developed except for the socket fit comfort score[4] and PEQ-RLH[5].

iii) Visit Schedule and forms to fill out There are at least four scheduled study events. Each visit, except when fitting to trial product will take approximately 2 hours. The trial product fitting visits (event nr. 2, 2a, 2b, etc.) should last for no more than 30 minutes.

The first event is a visit within the normal treatment procedures of prosthetic care when the users are measured for a new socket. The ICF will be signed prior to any study activity. During the visit the subjects will also fill in the User Profile and Baseline instruments, with the help of their CPO as required.

This test, as is standard for liner testing, requires that the users will be fitted with a new socket. Attaining a proper fit of a new socket requires at least one iteration, often more, and few days to complete, and hence some users might require more study visits than others.

The second study event will be 1-2 weeks post first visit, when the new socket is ready. Subjects will come in and fit the new socket while wearing the investigational device. To verify that the socket is acceptable subjects will be asked to fill in the Socket fitting instrument. If the outcome is positive the subject will be scheduled for the 2 week follow up and subject goes home with the new prosthetic liner. If not, a new socket must be made or adjustments to the one manufactured and another visit set up for this event.

The third study event is the 2 week follow up. During the visit the subject will fill in the 2 week follow up instrument and the Retrofitting instrument, after retrofitting. Subject keeps using the investigational device.

The final study event, and expected fourth visit, is at 6 months post successful fitting. The subject fills in the 6 month follow up instrument, receives compensation as applicable and ends study participation.

The subjects will return the trial device at the 6 month visit.

02

Conditions studied

  • Amputation Stumps
03

In context

Lead sponsor

Össur Iceland ehf is the lead sponsor of 24 studies on the registry; 5 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 8 (80%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Cognitive ability to understand all instructions and questionnaires in the study
  • Bi- or unilateral transtibial amputee, low to moderate impact
  • Amputee currently using a cushion (n=10) or a locking (n=10) 3 or 6 mm OWW Alpha Classic Uniform, or 3 mm OWW Alpha Classic Tapered liner
  • Willing and able to participate in the study and follow the protocol
  • Confident prosthetic users for more than 3 months
  • Older than 18 years

Exclusion criteria

Exclusion Criteria:

  • Users with cognitive impairment
  • Transfemoral amputees
  • Amputees not using a prosthesis for daily activities
  • Amputees not using OWW Alpha Classic cushion (n=10) or a locking (n=10), 3 or 6 mm OWW Alpha Classic Uniform, or 3 mm OWW Alpha Classic Tapered liners, as part of their primary prosthesis
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    Treatment Group

    New TPE liner: Subjects get a new socket and are fitted with a new liner under development. Subjects use the liner for 6 months.

    Device: TPE Liner

Interventions

  • DeviceTPE Liner

    Subjects are asked to change their primary prosthetic liner. This entails getting a new socket as well. Subjects are expected to use the new liner for up to 6 months. No other intervention is planned.

06

What researchers measure

Primary outcomes

  1. Perceived Suspension Quality Score

    Suspension Score: Suspension quality was assessed using an in-house developed questionnaire consisting of 7 items evaluating perceived prosthetic suspension and security throughout the day. The items assessed stability in the socket, suspension in the morning, afternoon, and evening, vertical movement (pistoning), rotational movement, and the influence of perspiration on suspension. Each item was rated on a 10-cm Visual Analog Scale (VAS) ranging from 0 to 10. Depending on the item, 0 represented the poorest suspension outcome (e.g., completely disagree, extreme influence of perspiration) and 10 represented the best suspension outcome (e.g., completely agree, no influence of perspiration). Item scores were averaged to obtain an overall suspension score ranging from 0 to 10, with higher scores indicating better perceived suspension quality and security.

    Time frame: 2 weeks

  2. Residual Limb Health Subscale Score (Average of 6 Items)

    Residual Limb Health Subscale Score (average of 6 items). Residual limb health was assessed using the Prosthetic Evaluation Questionnaire - Residual Limb Health (PEQ-RLH) subscale, which evaluates sweating, odor, swelling, rashes, ingrown hairs, and sores or blisters on the residual limb. Participants rated each item on a 10-cm Visual Analog Scale (VAS) ranging from 0 to 10, where 0 represents the poorest residual limb health (most severe symptoms) and 10 represents the best residual limb health (no symptoms). The overall PEQ-RLH score was calculated as the mean of the six item scores, resulting in a total score ranging from 0 to 10. Higher scores indicate better residual limb health and fewer skin-related problems.

    Time frame: 2 weeks

  3. Number of Subjects That Drop Out Because of Dissatisfaction With the Liner (Not Socket Related).

    Number of participants who discontinued study participation because of dissatisfaction with the investigational liner, excluding discontinuations related to socket fit or socket-related issues. Lower values indicate better user acceptance of the investigational liner.

    Time frame: 6 months

Secondary outcomes

  1. Socket Fit Comfort VAS Score

    Socket Fit Comfort: Participants rated the comfort of socket fit using a 10-cm Visual Analog Scale (VAS). Scores ranged from 0 to 10, where 0 = extremely uncomfortable socket fit and 10 = extremely comfortable socket fit. Higher scores indicate better perceived socket fit comfort.

    Time frame: 2 weeks

  2. Participants Able to Use the Trial Liner as Their Primary Prosthesis

    Number of participants able to use the investigational liner as their primary prosthesis during the study period. Higher values indicate successful use of the liner under normal conditions of use.

    Time frame: 2 weeks

Other outcomes

  1. Satisfaction With Noise Generated During Prosthesis Use

    Participants rated the amount of noise generated while using the prosthesis on a 10-cm Visual Analog Scale (VAS) ranging from 0 to 10, where 0 represented the least favorable outcome and 10 represented the most favorable outcome. Higher scores indicate greater satisfaction with the amount of noise generated during prosthesis use.

    Time frame: 2 weeks

07

Results

Posted Sep 11, 2026

Participant flow

Participant flow — Overall Study
MilestoneTreatment Group
Started14
Completed11
Not completed3

Outcome measures

PrimaryPerceived Suspension Quality Score

Suspension Score: Suspension quality was assessed using an in-house developed questionnaire consisting of 7 items evaluating perceived prosthetic suspension and security throughout the day. The items assessed stability in the socket, suspension in the morning, afternoon, and evening, vertical movement (pistoning), rotational movement, and the influence of perspiration on suspension. Each item was rated on a 10-cm Visual Analog Scale (VAS) ranging from 0 to 10. Depending on the item, 0 represented the poorest suspension outcome (e.g., completely disagree, extreme influence of perspiration) and 10 represented the best suspension outcome (e.g., completely agree, no influence of perspiration). Item scores were averaged to obtain an overall suspension score ranging from 0 to 10, with higher scores indicating better perceived suspension quality and security.

Time frame:
2 weeks
Reported as:
Mean · score on a scale
Perceived Suspension Quality Score
score on a scaleTreatment GroupBaseline
Perceived Suspension Quality Score9.26 ± 0.68.1 ± 0.45
PrimaryResidual Limb Health Subscale Score (Average of 6 Items)

Residual Limb Health Subscale Score (average of 6 items). Residual limb health was assessed using the Prosthetic Evaluation Questionnaire - Residual Limb Health (PEQ-RLH) subscale, which evaluates sweating, odor, swelling, rashes, ingrown hairs, and sores or blisters on the residual limb. Participants rated each item on a 10-cm Visual Analog Scale (VAS) ranging from 0 to 10, where 0 represents the poorest residual limb health (most severe symptoms) and 10 represents the best residual limb health (no symptoms). The overall PEQ-RLH score was calculated as the mean of the six item scores, resulting in a total score ranging from 0 to 10. Higher scores indicate better residual limb health and fewer skin-related problems.

Time frame:
2 weeks
Reported as:
Mean · score on a scale
Residual Limb Health Subscale Score (Average of 6 Items)
score on a scaleTreatment GroupBaseline
Residual Limb Health Subscale Score (Average of 6 Items)9.02 ± 1.067.7 ± 1.34
PrimaryNumber of Subjects That Drop Out Because of Dissatisfaction With the Liner (Not Socket Related).

Number of participants who discontinued study participation because of dissatisfaction with the investigational liner, excluding discontinuations related to socket fit or socket-related issues. Lower values indicate better user acceptance of the investigational liner.

Time frame:
6 months
Reported as:
Count of participants · Participants
Number of Subjects That Drop Out Because of Dissatisfaction With the Liner (Not Socket Related).
ParticipantsTreatment Group
Number of Subjects That Drop Out Because of Dissatisfaction With the Liner (Not Socket Related).0
SecondarySocket Fit Comfort VAS Score

Socket Fit Comfort: Participants rated the comfort of socket fit using a 10-cm Visual Analog Scale (VAS). Scores ranged from 0 to 10, where 0 = extremely uncomfortable socket fit and 10 = extremely comfortable socket fit. Higher scores indicate better perceived socket fit comfort.

Time frame:
2 weeks
Reported as:
Mean · score on a scale
Socket Fit Comfort VAS Score
score on a scaleTreatment GroupBaseline
Socket Fit Comfort VAS Score8.81 ± 0.758.13 ± 0.63
SecondaryParticipants Able to Use the Trial Liner as Their Primary Prosthesis

Number of participants able to use the investigational liner as their primary prosthesis during the study period. Higher values indicate successful use of the liner under normal conditions of use.

Time frame:
2 weeks
Reported as:
Count of participants · Participants
Participants Able to Use the Trial Liner as Their Primary Prosthesis
ParticipantsTreatment Group
Participants Able to Use the Trial Liner as Their Primary Prosthesis14
Other pre-specifiedSatisfaction With Noise Generated During Prosthesis Use

Participants rated the amount of noise generated while using the prosthesis on a 10-cm Visual Analog Scale (VAS) ranging from 0 to 10, where 0 represented the least favorable outcome and 10 represented the most favorable outcome. Higher scores indicate greater satisfaction with the amount of noise generated during prosthesis use.

Time frame:
2 weeks
Reported as:
Mean · Score on a scale
Satisfaction With Noise Generated During Prosthesis Use
Score on a scaleTreatment Group
Satisfaction With Noise Generated During Prosthesis Use7.47 ± 0.5

Adverse events

Collected over Data on adverse events was collected for the duration of the study, 6 months.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Treatment Group0/14 (0%)0/14 (0%)3/14 (21.4%)
Most frequent other events
Most frequent other events
EventTreatment Group
Skin reactionSkin and subcutaneous tissue disorders2/14
FallProduct Issues1/14

Baseline characteristics

Age, Continuous
Age, Continuous(years)Treatment Group
Mean56.5 ± 16
Sex: Female, Male
Sex: Female, Male(Participants)Treatment Group
Female2
Male12
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Treatment Group
08

Study locations

1 site
  • Valley Institute of Prosthetics and Orthotics, Inc.
    Bakersfield, California 93301, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Mar 2016 to primary completion in Nov 2018, 31 months.

Results were first posted in Sep 2026, 7 years 9 months after primary completion.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 19, 2015
First posted
Dec 7, 2015
StartActual
Mar 30, 2016
Primary completionActual
Nov 15, 2018
CompletionActual
Jan 30, 2019
Results first posted
Sep 11, 2026
Last update
Sep 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02622919
Lead sponsor
Össur Iceland ehf
Responsible party
Sponsor
First posted
Dec 7, 2015
Start date
Mar 30, 2016
Primary completion
Nov 15, 2018
Completion
Jan 30, 2019
Results posted
Sep 11, 2026
Last update
Sep 11, 2026

Study contacts

Justin Pratt, CPO
principal investigator · Össur

Oversight

Data monitoring committee
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion